Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique
Information source: Mayo Clinic
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Penicillin Allergy
Intervention: penicillin skin test (Other)
Phase: N/A
Status: Withdrawn
Sponsored by: Mayo Clinic
Summary
The primary objective of the study is to evaluate the equivalency of the skin test
reactivity to penicilloate prepared by our new method of penicilloate preparation versus our
old method of penicilloate preparation. The secondary objective of the study is to evaluate
the significance of the different diastereoisomers of penicilloate on skin test reactivity.
Clinical Details
Official title: Equivalency of Penicilloate Skin Test Reactivity Prepared by a Modified Alkaline Hydrolysis Technique
Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Primary outcome: The primary objective of the study is to evaluate the equivalency of the skin test reactivity to penicilloate prepared by our new method of penicilloate preparation versus our old method of penicilloate preparation.
Secondary outcome: The secondary objective of the study is to evaluate the significance of the different diastereoisomers of penicilloate on skin test reactivity.
Detailed description:
The primary objective of the study is to evaluate the equivalency of the skin test
reactivity to penicilloate prepared by our new method of penicilloate preparation versus our
old method of penicilloate preparation. The secondary objective of the study is to evaluate
the significance of the different diastereoisomers of penicilloate on skin test reactivity.
Five (5) adult subjects without a history of penicillin allergy and fifteen (15) adult
subjects with a history of penicillin allergy and previous positive penicillin skin test to
the minor determinant (penicilloate) and/or major determinant (penicilloyl) will be enrolled
into the study. Each subject will be skin tested with our current penicillin skin test
which includes penicilloate conducted in the Division of Allergic Diseases will be compared
the skin test of our penicilloate prepared by our newer method along with the different
diastereoisomers of penicilloic acid on the same day and time. The adult subjects without a
history of penicillin allergy will serve as our control.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. History of penicillin allergy
2. Previous or current positive skin test to penicilloate
3. Greater than or equal to 18 years of age
Exclusion Criteria:
1. Uncontrolled asthma by symptoms
2. Patients who have received penicillin and had no adverse drug reaction
3. Previous adverse reaction to penicillin skin test
4. Dermatological conditions that may interfere with skin testing i. e. atopic dermatitis
and dermatographism
5. Medication that may interfere with skin testing i. e. antidepressants, antihistamines,
and sedatives.
Locations and Contacts
Additional Information
Mayo Clinic Clinical Trials
Starting date: June 2008
Last updated: December 14, 2011
|